India's indigenous CRISPR-based gene-editing therapy for sickle cell disease: innovation to equitable implementation. // The Lancet Regional Health - Southeast Asia. – URL: https://www.sciencedirect.com/science/article/pii/S277236822600168X?dgcid=rss_sd_all
India's indigenous CRISPR-based gene-editing therapy for sickle cell disease: innovation to equitable implementation. The Lancet Regional Health - Southeast Asia. https://www.sciencedirect.com/science/article/pii/S277236822600168X?dgcid=rss_sd_all
“India's indigenous CRISPR-based gene-editing therapy for sickle cell disease: innovation to equitable implementation.” The Lancet Regional Health - Southeast Asia.
@article{article69164,
title = {India's indigenous CRISPR-based gene-editing therapy for sickle cell disease: innovation to equitable implementation},
journal = {The Lancet Regional Health - Southeast Asia},
url = {https://www.sciencedirect.com/science/article/pii/S277236822600168X?dgcid=rss_sd_all}
}